Literature DB >> 27638811

A population study of the reported incidence of native joint septic arthritis in the United Kingdom between 1998 and 2013.

Andrew I Rutherford1, Sujith Subesinghe2, Tehmina Bharucha3, Fowzia Ibrahim2, Alexander Kleymann4, James B Galloway2.   

Abstract

OBJECTIVES: Septic arthritis is a life-threatening condition with mortality rates of 10-15%. Previous studies in other countries have shown the incidence of septic arthritis may be changing. Our aim was investigate the incidence and pattern of native joint septic arthritis in the UK.
METHODS: We performed an analysis using Hospital Episode Statistics to investigate the reported incidence of septic arthritis in the UK between 1998 and 2013.
RESULTS: A total of 54 532 cases of septic arthritis were reported via Hospital Episode Statistics during the timeframe studied. There has been a 43% increase in the reported incidence of septic arthritis, with rates rising from 5.5/100 000 in 1998 to 7.8/100 000 in 2013. The rate increased most rapidly in those >75 years of age (15/100 000 in 1998 and 31/100 000 in 2013). Staphylococcal species were the most frequently reported, followed by Streptococcus Pneumococcus rates were relatively stable, with the exception of a 7-fold spike in reported incidence in 2011. DISCUSSION: This large population-based study demonstrates that the incidence of septic arthritis is increasing in the UK. Rates are increasing most rapidly in the >75 years age group, which is likely the result of increasing co-morbidities. The clustering of pneumococcal cases has potential public health implications.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  arthritis; bacterial; biologics; epidemiology; incidence; infection; pneumococcus; population; septic; streptococcus

Mesh:

Year:  2016        PMID: 27638811     DOI: 10.1093/rheumatology/kew323

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

Review 1.  [Native joint infections].

Authors:  Heinrich M L Mühlhofer; Susanne Feihl; Ingo J Banke; Christian Suren; Florian Pohlig; Rüdiger von Eisenhart-Rothe
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

2.  The Epidemiology and Outcomes of Septic Arthritis in the Maltese Islands: A Hospital-Based Retrospective Cohort Study.

Authors:  Christian Vassallo; Andrew A Borg; Daniel Farrugia; Cecilia Mercieca
Journal:  Mediterr J Rheumatol       Date:  2020-06-30

3.  Measuring complications of serious pediatric emergencies using ICD-10.

Authors:  Kenneth A Michelson; Arianna H Dart; Richard G Bachur; Prashant Mahajan; Jonathan A Finkelstein
Journal:  Health Serv Res       Date:  2020-12-29       Impact factor: 3.402

4.  Group B streptococcus is the most common pathogen for septic arthritis with unique clinical characteristics: data from 12 years retrospective cohort study.

Authors:  Rungkan Ruksasakul; Pongthorn Narongroeknawin; Paijit Assavatanabodee; Sumapa Chaiamnuay
Journal:  BMC Rheumatol       Date:  2019-09-16

5.  Native joint infections in Iceland 2003-2017: an increase in postarthroscopic infections.

Authors:  Signý Lea Gunnlaugsdóttir; Helga Erlendsdóttir; Kristján Orri Helgason; Árni Jón Geirsson; Valtýr Thors; Sigurður Guðmundsson; Magnús Gottfreðsson
Journal:  Ann Rheum Dis       Date:  2021-09-17       Impact factor: 19.103

6.  Mortality of septic knee arthritis in Korea: risk factors analysis of a large national database.

Authors:  Ho-Jun Choi; Han-Kook Yoon; Hyun-Cheol Oh; Jung-Hwa Hong; Taeyun Choi; Sang-Hoon Park
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

7.  How well does synovial fluid gram staining correlate with cultures in native joint infections?

Authors:  Herbert Gbejuade; Mohamed Elsakka; Lucy Cutler
Journal:  Orthop Rev (Pavia)       Date:  2019-12-02

8.  A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada.

Authors:  Kristen A Morin; Chad R Prevost; Joseph K Eibl; Michael T Franklyn; Alexander R Moise; David C Marsh
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.